Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Change in Receivables: 2009-2025

Historic Change in Receivables for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to -$22.4 million.

  • BIO-TECHNE's Change in Receivables fell 3.84% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.0 million, marking a year-over-year decrease of 339.97%. This contributed to the annual value of -$34.1 million for FY2025, which is 266.23% down from last year.
  • As of Q3 2025, BIO-TECHNE's Change in Receivables stood at -$22.4 million, which was up 22.41% from -$28.9 million recorded in Q2 2025.
  • BIO-TECHNE's Change in Receivables' 5-year high stood at $51.6 million during Q1 2022, with a 5-year trough of -$28.9 million in Q2 2025.
  • In the last 3 years, BIO-TECHNE's Change in Receivables had a median value of $92,000 in 2023 and averaged -$336,273.
  • As far as peak fluctuations go, BIO-TECHNE's Change in Receivables crashed by 576.63% in 2022, and later spiked by 19,380.43% in 2024.
  • BIO-TECHNE's Change in Receivables (Quarterly) stood at $5.7 million in 2021, then rose by 3.50% to $5.9 million in 2022, then slumped by 180.10% to -$4.7 million in 2023, then spiked by 113.16% to $623,000 in 2024, then dropped by 3.84% to -$22.4 million in 2025.
  • Its Change in Receivables was -$22.4 million in Q3 2025, compared to -$28.9 million in Q2 2025 and $15.7 million in Q1 2025.